Furthermore, paediatric neuroblastoma patients in each dataset were divided into TP53 higher and lower subgroups based on the mRNA expression levels of TP53. The different clinical outcomes of TP53 higher and lower subgroups were determined by Kaplan–Meier survival analysis. Here, TP53 is linked to neuroblastoma.